Search Results - "Huygens, Simone A."

The Ross Procedure: A Systematic Review, Meta-Analysis, and Microsimulation by Etnel, Jonathan R G, Grashuis, Pepijn, Huygens, Simone A, Pekbay, Begüm, Papageorgiou, Grigorios, Helbing, Willem A, Roos-Hesselink, Jolien W, Bogers, Ad J J C, Mokhles, M Mostafa, Takkenberg, Johanna J M

“…To support decision-making in aortic valve replacement in children and adults, we provide a comprehensive overview of outcome after the Ross procedure. A…”
Get full text

Effectiveness and Cost-Effectiveness of 360 Disease-Modifying Treatment Escalation Sequences in Multiple Sclerosis by Versteegh, Matthijs M., Huygens, Simone A., Wokke, Beatrijs W.H., Smolders, Joost

“…The rapid expansion in treatment options for relapsing-remitting multiple sclerosis (RRMS) of the past decade requires clinical decision making on the…”
Get full text

Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision by Huygens, Simone A., Versteegh, Matthijs M., Vegter, Stefan, Schouten, L. Jan, Kanters, Tim A.

“…The emergence of gene therapies challenge health economists to evaluate interventions that are often provided to a small patient population with a specific…”
Get full text

Bioprosthetic Aortic Valve Replacement in Nonelderly Adults: A Systematic Review, Meta-Analysis, Microsimulation by Etnel, Jonathan R G, Huygens, Simone A, Grashuis, Pepijn, Pekbay, Begüm, Papageorgiou, Grigorios, Roos Hesselink, Jolien W, Bogers, Ad J J C, Takkenberg, Johanna J M

“…Background To support decision-making in aortic valve replacement in nonelderly adults, we aim to provide a comprehensive overview of reported outcome after…”
Get full text

How microsimulation translates outcome estimates to patient lifetime event occurrence in the setting of heart valve disease by Notenboom, Maximiliaan L, Rhellab, Reda, Etnel, Jonathan R G, Huygens, Simone A, Hjortnaes, Jesper, Kluin, Jolanda, Takkenberg, Johanna J M, Veen, Kevin M

“…Treatment decisions in healthcare often carry lifelong consequences that can be challenging to foresee. As such, tools that visualize and estimate outcome…”
Get full text

What Is the Potential of Tissue-Engineered Pulmonary Valves in Children? by Huygens, Simone A., Rutten-van Mölken, Maureen P.M.H., Noruzi, Anahita, Etnel, Jonathan R.G., Corro Ramos, Isaac, Bouten, Carlijn V.C., Kluin, Jolanda, Takkenberg, Johanna J.M.

“…As a living heart valve substitute with growth potential and improved durability, tissue-engineered heart valves (TEHVs) may prevent reinterventions that are…”
Get full text

Bioprosthetic aortic valve replacement in elderly patients: Meta-analysis and microsimulation by Huygens, Simone A., Etnel, Jonathan R.G., Hanif, Milad, Bekkers, Jos A., Bogers, Ad J.J.C., Rutten-van Mölken, Maureen P.M.H., Takkenberg, Johanna J.M.

“…To support decision-making in aortic valve replacement (AVR) in elderly patients, we provide a comprehensive overview of outcome after AVR with bioprostheses…”
Get full text

Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model by Corsten, Cato E.A., Huygens, Simone A., Versteegh, Matthijs M., Wokke, Beatrijs H.A., Smets, Ide, Smolders, Joost

“…•Disease-modifying therapies (DMTs) are the largest cost driver in MS.•Three sphingosine-1-phosphate receptor (S1PR) modulators are used for relapsing MS.•Our…”
Get full text

Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands by Santi, Irene, Vellekoop, Heleen, M Versteegh, Matthijs, A Huygens, Simone, Dinjens, Winand N. M., Mölken, Maureen Rutten-van

“…Objectives We evaluated the prognostic value of the neurotrophic tyrosine receptor kinase ( NTRK ) gene fusions by comparing the survival of patients with…”
Get full text

Contemporary outcomes after surgical aortic valve replacement with bioprostheses and allografts: a systematic review and meta-analysis by Huygens, Simone A., Mokhles, Mostafa M., Hanif, Milad, Bekkers, Jos A., Bogers, Ad J.J.C., Rutten-van Mölken, Maureen P.M.H., Takkenberg, Johanna J.M.

“…Many observational studies have reported outcomes after surgical aortic valve replacement (AVR), but there are no recent systematic reviews and meta-analyses…”
Get full text

Beyond the clinical impact of aortic and pulmonary valve implantation: health-related quality of life, informal care and productivity by Huygens, Simone A, van der Kley, Frank, Bekkers, Jos A, Bogers, Ad J J C, Takkenberg, Johanna J M, Rutten-van Mölken, Maureen P M H

“…Abstract OBJECTIVES Our aim was to provide estimates of patient-reported health-related quality of life (HRQoL), use of informal care and productivity in…”
Get full text

Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients by Huygens, Simone A., Ramos, Isaac Corro, Bouten, Carlijn V. C., Kluin, Jolanda, Chiu, Shih Ting, Grunkemeier, Gary L., Takkenberg, Johanna J. M., Mölken, Maureen P. M. H. Rutten-van

“…Objectives Aortic valve disease is the most frequent indication for heart valve replacement with the highest prevalence in elderly. Tissue-engineered heart…”
Get full text

Systematic review of model-based economic evaluations of heart valve implantations by Huygens, Simone A., Takkenberg, Johanna. J. M., Rutten-van Mölken, Maureen P. M. H.

“…Objective To review the evidence on the cost-effectiveness of heart valve implantations generated by decision analytic models and to assess their…”
Get full text

Outcomes after surgery for functional tricuspid regurgitation: a systematic review and meta-analysis by Veen, Kevin M, Etnel, Jonathan R G, Quanjel, Thijs J M, Mokhles, Mostafa M, Huygens, Simone A, Rasheed, Moniba, Oei, Frans B S, ten Cate, Folkert J, Bogers, Ad J J C, Takkenberg, Johanna J M

“…Abstract Aims This study aims to provide a contemporary overview of outcomes after tricuspid valve (TV) surgery for functional tricuspid regurgitation (TR)…”
Get full text

How much does a heart valve implantation cost and what are the health care costs afterwards? by Huygens, Simone A, Goossens, Lucas M A, van Erkelens, Judith A, Takkenberg, Johanna J M, Rutten-van Mölken, Maureen P M H

“…ObjectiveIn the era of limited healthcare budgets, healthcare costs of heart valve implantations need to be considered to inform cost-effectiveness analyses…”
Get full text

Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer by Holleman, Marscha S., Huygens, Simone A., Al, Maiwenn J., Kuppen, Malou C. P., Westgeest, Hans M., van den Bergh, Alfonsus C. M., Bergman, Andries M., van den Eertwegh, Alfonsus J. M., Hendriks, Mathijs P., Lampe, Menuhin I., Mehra, Niven, van Moorselaar, Reindert J. A., van Oort, Inge M., Somford, Diederik M., de Wit, Ronald, van de Wouw, Agnes J., Gerritsen, Winald R., Groot, Carin A. Uyl-de

“…Background Real-world disease models spanning multiple treatment lines can provide insight into the (cost) effectiveness of treatment sequences in clinical…”
Get full text

Exploring the variation in implementation of a COPD disease management programme and its impact on health outcomes: a post hoc analysis of the RECODE cluster randomised trial by Boland, Melinde R S, Kruis, Annemarije L, Huygens, Simone A, Tsiachristas, Apostolos, Assendelft, Willem J J, Gussekloo, Jacobijn, Blom, Coert M G, Chavannes, Niels H, Rutten-van Mölken, Maureen P M H

“…This study aims to (1) examine the variation in implementation of a 2-year chronic obstructive pulmonary disease (COPD) management programme called RECODE, (2)…”
Get full text

Conceptual model for early health technology assessment of current and novel heart valve interventions by Huygens, Simone A, Rutten-van Mölken, Maureen P M H, Bekkers, Jos A, Bogers, Ad J J C, Bouten, Carlijn V C, Chamuleau, Steven A J, de Jaegere, Peter P T, Kappetein, Arie Pieter, Kluin, Jolanda, van Mieghem, Nicolas M D A, Versteegh, Michel I M, Witsenburg, Maarten, Takkenberg, Johanna J M

“…ObjectiveThe future promises many technological advances in the field of heart valve interventions, like tissue-engineered heart valves (TEHV). Prior to…”
Get full text

The Risk in Avoiding Risk: Optimizing Decision Making in Structural Heart Disease Interventions by Mokhles, Mostafa M., Huygens, Simone A., Takkenberg, Johanna J. M.

“…Due to public audit of operative mortality after cardiac surgery, surgeons tend to avoid procedures with high early mortality risk. However there may be…”
Get full text

Cost-Effectiveness and Projected Survival of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement for High Risk Patients in a European Setting: A Dutch Analysis Based on the CoreValve High Risk Trial by Geisler, Benjamin P., Huygens, Simone A., Reardon, Michael J., Van Mieghem, Nicolas, Kappetein, Arie Pieter, Osnabrugge, Ruben L. J., Pietzsch, Jan B.

“…Background: Clinical and economic outcomes of self-expanding bioprosthetic transcatheter aortic valve implantation (TAVI) in high-risk surgical candidates are…”
Get full text